CRON

2.05

1.99% 0.04

Handel nachbörslich: 2.06 0.01 +0.49%

Cronos Group Inc (CRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.01

Offen:

$2.005

24-Stunden-Volumen:

1.25M

Relative Volume:

1.26

Marktkapitalisierung:

$783.70M

Einnahmen:

$87.89M

Nettoeinkommen (Verlust:

$-73.96M

KGV:

-5.3947

EPS:

-0.38

Netto-Cashflow:

$-46.26M

1W Leistung:

-0.97%

1M Leistung:

-3.76%

6M Leistung:

-25.99%

1J Leistung:

+0.99%

1-Tages-Spanne:

$2.00

$2.10

1-Wochen-Bereich:

$1.99

$2.105

52-Wochen-Spanne:

$1.85

$3.14

Cronos Group Inc Stock (CRON) Company Profile

Firmenname

Cronos Group Inc

Sektor

Healthcare (1195)

Branche

Drug Manufacturers - Specialty & Generic (87)

Telefon

(416) 504-0004

Adresse

4491 CONCESSION RD 12, STAYNER, ON

Mitarbeiter

356

Twitter

@cronosgroup

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

CRON's Discussions on Twitter

Vergleichen Sie CRON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRON	2.05	783.70M	87.89M	-73.96M	-46.26M	-0.38
ZTS	176.71	79.55B	9.15B	2.43B	2.31B	4.92
HLN	9.55	43.18B	14.26B	1.55B	0	0.3327
TAK	13.33	42.26B	30.27B	1.93B	3.45B	0.444
TEVA	17.08	19.35B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.25	15.77B	15.24B	-646.50M	1.88B	1.53

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-28	Hochstufung	Canaccord Genuity	Hold → Buy
2022-05-11	Hochstufung	CIBC	Neutral → Sector Outperform
2022-03-22	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-27	Hochstufung	Jefferies	Underperform → Hold
2021-11-18	Fortgesetzt	BofA Securities	Underperform
2021-04-28	Fortgesetzt	BofA Securities	Underperform
2021-02-22	Herabstufung	CIBC	Sector Outperform → Neutral
2020-06-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-04-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-14	Herabstufung	Piper Sandler	Overweight → Neutral
2020-04-02	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-31	Herabstufung	Canaccord Genuity	Hold → Sell
2020-03-04	Hochstufung	MKM Partners	Neutral → Buy
2020-03-03	Herabstufung	Stifel	Buy → Hold
2019-10-18	Hochstufung	Stifel	Hold → Buy
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-09-05	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Eingeleitet	Piper Jaffray	Overweight
2019-08-09	Hochstufung	Canaccord Genuity	Sell → Hold
2019-06-28	Eingeleitet	Consumer Edge Research	Equal Weight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Hochstufung	BofA/Merrill	Underperform → Buy
2019-04-17	Eingeleitet	BofA/Merrill	Underperform
2019-03-27	Herabstufung	Canaccord Genuity	Hold → Sell
2019-02-25	Eingeleitet	Jefferies	Underperform
2019-01-18	Eingeleitet	CIBC	Sector Outperform

Alle ansehen

Cronos Group Inc Aktie (CRON) Neueste Nachrichten

Nov 20, 2024

Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis - Benzinga

Nov 14, 2024

Roth Capital Lowers Earnings Estimates for Cronos Group - MarketBeat

Nov 14, 2024

Cronos Group (STU:7CI) Long-Term Debt & Capital Lease Obligation : €0.99 Mil (As of Jun. 2024) - GuruFocus.com

Nov 14, 2024

Cronos Group (STU:7CI) Short-Term Capital Lease Obligation : €0.87 Mil (As of Jun. 2024) - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Cronos: Q3 Earnings Snapshot - MSN

Nov 13, 2024

CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com

Nov 13, 2024

Cronos Group Inc. (NASDAQ:CRON) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Earnings call: Cronos Group sees robust growth with record revenue - Investing.com India

Nov 13, 2024

Earnings call: Cronos Group sees robust growth with record revenue By Investing.com - Investing.com UK

Nov 13, 2024